Cancer doctors push Congress to help end drug shortages
U.S. regulators and the country's top cancer doctors urged Congress to help end the shortages of more than a hundred drugs, including those for deadly tumors. The House and Senate are working to merge bills passed last week that would require drugmakers to notify the Food and Drug Administration when they expect a disruption to production of medicines. The number of shortages have tripled since 2006 and include cisplatin for ovarian cancer and paclitaxel, a therapy given to women with breast cancer.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CA Powers Up $80M HIE to 'Create Value in the Data'
- 3 Traits Personality Assessments Can't Reveal